CORMEDIX INC. - COMMON STOCK

CorMedix Inc. Announces New Commercial Agreement

19 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

13 9 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

09 9 2024 09:52:30 提供 Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

14 8 2024 06:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

07 8 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces Outpatient Availability of DefenCath

03 7 2024 07:00:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 6 2024 07:00:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

06 6 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

10 5 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

09 5 2024 06:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06 5 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

19 4 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

15 4 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference

11 4 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

08 4 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Needham Annual Healthcare Conference

27 3 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

12 3 2024 06:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

06 3 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Reimbursement Updates

30 1 2024 07:30:00 提供 Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Operational Updates

08 1 2024 07:30:00 提供 Nasdaq GlobeNewswire